Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79


Usability of a novel digital medicine system in adults with schizophrenia treated with sensor-embedded tablets of aripiprazole.

Peters-Strickland T, Pestreich L, Hatch A, Rohatagi S, Baker RA, Docherty JP, Markovtsova L, Raja P, Weiden PJ, Walling DP.

Neuropsychiatr Dis Treat. 2016 Oct 11;12:2587-2594. eCollection 2016.


A multicenter, open-label, pilot study evaluating the functionality of an integrated call center for a digital medicine system to optimize monitoring of adherence to oral aripiprazole in adult patients with serious mental illness.

Kopelowicz A, Baker RA, Zhao C, Brewer C, Lawson E, Peters-Strickland T.

Neuropsychiatr Dis Treat. 2017 Oct 19;13:2641-2651. doi: 10.2147/NDT.S143091. eCollection 2017.


Developing a Digital Medicine System in Psychiatry: Ingestion Detection Rate and Latency Period.

Profit D, Rohatagi S, Zhao C, Hatch A, Docherty JP, Peters-Strickland TS.

J Clin Psychiatry. 2016 Sep;77(9):e1095-e1100. doi: 10.4088/JCP.16m10643.


First experience with a wireless system incorporating physiologic assessments and direct confirmation of digital tablet ingestions in ambulatory patients with schizophrenia or bipolar disorder.

Kane JM, Perlis RH, DiCarlo LA, Au-Yeung K, Duong J, Petrides G.

J Clin Psychiatry. 2013 Jun;74(6):e533-40. doi: 10.4088/JCP.12m08222.


Optimization of a Digital Medicine System in Psychiatry.

Rohatagi S, Profit D, Hatch A, Zhao C, Docherty JP, Peters-Strickland TS.

J Clin Psychiatry. 2016 Sep;77(9):e1101-e1107. doi: 10.4088/JCP.16m10693.


Performance, Reliability, Usability, and Safety of the ID-Cap System for Ingestion Event Monitoring in Healthy Volunteers: A Pilot Study.

Flores GP, Peace B, Carnes TC, Baumgartner SL, Buffkin DE Jr, Euliano NR, Smith LN.

Innov Clin Neurosci. 2016 Oct 1;13(9-10):12-19. eCollection 2016 Sep-Oct.


Human factors evaluation of a novel digital medicine system in psychiatry.

Peters-Strickland T, Hatch A, Adenwala A, Atkinson K, Bartfeld B.

Neuropsychiatr Dis Treat. 2018 Feb 16;14:553-565. doi: 10.2147/NDT.S157102. eCollection 2018.


A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) study.

Kerwin R, Millet B, Herman E, Banki CM, Lublin H, Pans M, Hanssens L, L'Italien G, McQuade RD, Beuzen JN.

Eur Psychiatry. 2007 Oct;22(7):433-43. Epub 2007 Jun 7.


A 64-week, multicenter, open-label study of aripiprazole effectiveness in the management of patients with schizophrenia or schizoaffective disorder in a general psychiatric outpatient setting.

Hsieh MH, Lin WW, Chen ST, Chen KC, Chen KP, Chiu NY, Huang C, Chang CJ, Lin CH, Lai TJ.

Ann Gen Psychiatry. 2010 Sep 17;9:35. doi: 10.1186/1744-859X-9-35.


A randomized, open-label comparison of 2 switching strategies to aripiprazole treatment in patients with schizophrenia: add-on, wait, and tapering of previous antipsychotics versus add-on and simultaneous tapering.

Takeuchi H, Suzuki T, Uchida H, Nakajima S, Nomura K, Kikuchi T, Manki H, Watanabe K, Kashima H.

J Clin Psychopharmacol. 2008 Oct;28(5):540-3. doi: 10.1097/JCP.0b013e3181842586.


A 12-week, naturalistic switch study of the efficacy and tolerability of aripiprazole in stable outpatients with schizophrenia or schizoaffective disorder.

Kim CY, Chung S, Lee JN, Kwon JS, Kim DH, Kim CE, Jeong B, Jeon YW, Lee MS, Jun TY, Jung HY.

Int Clin Psychopharmacol. 2009 Jul;24(4):181-8. doi: 10.1097/YIC.0b013e32832c25d7.


Digital Health Intervention for Asthma: Patient-Reported Value and Usability.

Merchant R, Inamdar R, Henderson K, Barrett M, Su JG, Riley J, Van Sickle D, Stempel D.

JMIR Mhealth Uhealth. 2018 Jun 4;6(6):e133. doi: 10.2196/mhealth.7362.


Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than aripiprazole.

Potkin SG, Raoufinia A, Mallikaarjun S, Bricmont P, Peters-Strickland T, Kasper W, Baker RA, Eramo A, Sanchez R, McQuade R.

Curr Med Res Opin. 2013 Oct;29(10):1241-51. doi: 10.1185/03007995.2013.821973. Epub 2013 Jul 25.


A prospective, multicentre, open-label study of aripiprazole in the management of patients with schizophrenia in psychiatric practice in Europe: Broad Effectiveness Trial with Aripiprazole in Europe (EU-BETA).

Wolf J, Janssen F, Lublin H, Salokangas RK, Allain H, Smeraldi E, Bernardo M, Millar H, Pans M, Adelbrecht C, Laughton J, Werner C, Maier W.

Curr Med Res Opin. 2007 Oct;23(10):2313-23.


The Burden of Opioid-Induced Constipation: Discordance Between Patient and Health Care Provider Reports.

LoCasale RJ, Datto C, Wilson H, Yeomans K, Coyne KS.

J Manag Care Spec Pharm. 2016 Mar;22(3):236-45. doi: 10.18553/jmcp.2016.22.3.236.


A prospective, multicentre, open-label study to evaluate the effectiveness of aripiprazole in the treatment of a broad range of patients with schizophrenia.

Peuskens J, Bervoets C, Kok F, Delatte B, Touquet G, Gillain B, de Patoul A, Halkin V, Loze JY, Vansteelandt K, Constant E.

Eur Psychiatry. 2012 Oct;27(7):506-12. doi: 10.1016/j.eurpsy.2011.06.008. Epub 2011 Sep 14.


Preference of medicine and patient-reported quality of life in community-treated schizophrenic patients receiving aripiprazole vs standard of care: results from the STAR study.

Taylor D, Hanssens L, Loze JY, Pans M, L'Italien G, Marcus RN.

Eur Psychiatry. 2008 Aug;23(5):336-43. doi: 10.1016/j.eurpsy.2008.03.006. Epub 2008 Apr 18.


Patient-Centered Outcomes with Aripiprazole Once-Monthly for Maintenance Treatment in Patients with Schizophrenia: Results From Two Multicenter, Randomized, Double-Blind Studies.

Kane JM, Sanchez R, Baker RA, Eramo A, Peters-Strickland T, Perry PP, Johnson BR, Tsai LF, Carson WH, McQuade RD, Fleischhacker WW.

Clin Schizophr Relat Psychoses. 2015 Summer;9(2):79-87. doi: 10.3371/CSRP.KASA.022015. Epub 2015 Feb 24.


Novel Augmentation Strategies in Major Depression.

Martiny K.

Dan Med J. 2017 Apr;64(4). pii: B5338. Review.


Supplemental Content

Support Center